WO2018090576A1 - Flow blocking membrane and implanted medical device - Google Patents

Flow blocking membrane and implanted medical device Download PDF

Info

Publication number
WO2018090576A1
WO2018090576A1 PCT/CN2017/083719 CN2017083719W WO2018090576A1 WO 2018090576 A1 WO2018090576 A1 WO 2018090576A1 CN 2017083719 W CN2017083719 W CN 2017083719W WO 2018090576 A1 WO2018090576 A1 WO 2018090576A1
Authority
WO
WIPO (PCT)
Prior art keywords
film
reinforcing
mesh
lumen
stent
Prior art date
Application number
PCT/CN2017/083719
Other languages
French (fr)
Chinese (zh)
Inventor
刘香东
Original Assignee
先健科技(深圳)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 先健科技(深圳)有限公司 filed Critical 先健科技(深圳)有限公司
Publication of WO2018090576A1 publication Critical patent/WO2018090576A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2421Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with non-pivoting rigid closure members
    • A61F2/2424Ball valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2463Implants forming part of the valve leaflets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2475Venous valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00862Material properties elastic or resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections

Definitions

  • the invention relates to the field of implanted medical device technology, in particular to a flow blocking film and an implanted medical device having the same.
  • Common occluder devices for the treatment of congenital heart defects such as atrial septal defect, ventricular septal defect and patent foramen ovale generally include the left and right discs, the waist connecting the left and right discs, and the two discs and/or the waist.
  • the patent ductus arteriosus occluder includes a disc-like structure and a columnar waist and a baffle film disposed in the disc-like structure and/or the columnar waist.
  • the split left atrial appendage occluder generally includes a occlusion disk and a fixing frame for implanting the occlusion disk in the left atrial appendage in the left atrial appendage, and a choke membrane disposed in the occlusion disk.
  • the flow-blocking film may be made of polyester fiber for enhancing the plugging effect.
  • Both the prosthetic valve and the artificial blood vessel stent comprise a stent graft
  • the stent graft generally comprises a bare metal stent and a flow blocking membrane made of a polytetrafluoroethylene membrane covering the metal stent.
  • the mechanical strength of the above-mentioned baffle film is relatively low, especially when a prosthetic valve is fabricated, if the leaflet is sutured to the choke film on the bare metal support by a stitching process, the choke film is easily drawn by the suture. The hole makes it difficult to fix the choke film on the bare metal bracket, and the stitching yield is low.
  • the implanted medical device including the choke membrane, such as a congenital heart defect occluder, a left atrial appendage occluder, a prosthetic valve and an artificial blood vessel stent, are implanted in the human body, and the spoiler is sutured under the continuous impact of blood flow. It is easy to tear, and the tearing choke film easily falls off the stent or the occluder, shortening the service life of the medical device.
  • the choke membrane such as a congenital heart defect occluder, a left atrial appendage occluder, a prosthetic valve and an artificial blood vessel stent
  • the flow blocking film provided by the technical solution is to add a reinforcing layer on the existing flow blocking film, which comprises a film body provided with a reinforcing region and a reinforcing layer disposed in the reinforcing region.
  • the tensile strength of the reinforcing layer is greater than the tensile strength of the film body.
  • the reinforcing region may be provided on a surface of the film body, that is, a reinforcing layer is provided on a surface of the film body.
  • the reinforcing regions may be disposed on opposite surfaces of the two sets of films, and the baffle film is sandwiched between the two sets of films, that is, the reinforcing layer is disposed inside the film body .
  • the reinforcing layer may have the same shape and size as the film body, and a reinforcing layer may be disposed in a partial region of the film body according to actual needs.
  • the enhancement zone can be located at the edge of the baffle, by way of example, for a choke membrane in a congenital heart defect occluder or a split left atrial appendage occluder, the baffle can be rounded and reinforced The zone may be an annular region disposed at the edge of the baffle membrane.
  • the barrier film may have a cylindrical shape having the same shape and size as the lumen stent body, that is, the barrier film is completely covered and covered. The inner or outer surface of the membranous lumen stent coincides.
  • the reinforcing layer in the baffle film may include a plurality of reinforcing members staggered to form a reinforcing mesh having a cross structure; or all of the reinforcing members are parallel to each other; or a part of the plurality of reinforcing members
  • the reinforcing members are staggered to form a reinforcing mesh having a cross structure, and the other portions of the reinforcing members are parallel to each other.
  • the reinforcing mesh refers to a mesh structure in which meshes are formed between the cross structures, and may also refer to a structure in which the cross structures are closely arranged without meshes.
  • the tensile strength of the reinforcement is greater than the tensile strength of the film body.
  • the mesh of the reinforcing mesh ranges from 50 mesh to 120 mesh.
  • the reinforcement has a diameter ranging from 0.05 mm to 0.6 mm.
  • the thickness of the baffle film ranges from 0.06 mm to 0.72 mm.
  • the technical solution further includes providing an implantable medical device comprising the instrument body and the aforementioned flow blocking film, wherein a portion of the baffle film provided with the reinforcing layer is coupled to the instrument body.
  • the instrument body may be a device having a mesh-shaped plug disk such as a congenital heart defect occluder and a left atrial appendage occluder.
  • the baffle film is located in the occlusion disk, the reinforcement layer is located at the edge of the baffle film, and the reinforcement layer is sewn on the occlusion disk.
  • the instrument body may also include a lumen stent having a plurality of corrugated annular structures, the lumen stent having a hollow between at least two adjacent corrugated annular structures, the obturator membrane covering the At least one surface of the lumen support, such as an inner or outer surface, or both inner and outer surfaces, or may cover all of the aforementioned surface or only a portion of the inner or outer surface, ie, uncovered The surface is exposed to a partial hollow, and correspondingly, the hollow of the covered surface of the lumen support is covered by the choke film.
  • a distance between two points farthest from each other on the mesh of the reinforcing mesh is smaller than two farthest points on the annular structure having the smallest area
  • the distance between the at least one portion of the baffle film corresponding to the hollow covered by the baffle film contains a portion of the reinforcing layer.
  • the lumen stent may further include a membrane covering the other surface of the lumen stent, that is, the outer surface, the membrane It is connected to the choke film at the hollow.
  • the instrument body When the instrument body is a prosthetic valve, it further includes a leaflet covering the inner surface or the outer surface of the lumen stent, the leaflet being disposed in the lumen of the lumen stent, and Connected to the reinforcement layer in the baffle at the hollow.
  • the flow blocking film of the present invention includes a reinforcing member having a tensile strength higher than that of the film body.
  • the reinforcing members cooperate with each other to form a mesh, the suture can be directly passed through the mesh to suture the choke film to the instrument body at the hollow of the instrument body, for example, suturing the edge of the choke membrane to the congenital heart defect.
  • the mesh of the occluder is closed on the disc; or the choke film may be first covered on the instrument body having a hollow, such as a blood vessel support, and the reinforcement layer is correspondingly located at the hollow of the instrument body, and then the other components are passed through the suture Stitching onto the reinforcing layer of the baffle, such as suturing the leaflets to the baffle of the inner wall of the prosthetic valve stent.
  • the reinforcing member can restrict the suture sliding. Even if the reinforcing layer has no mesh, the suture passes through the reinforcing layer and is restricted from sliding due to the tensile strength of the reinforcing member itself, thereby preventing the chordal film from being drawn by the suture. Large openings to increase stitching yield and tensile strength at the seam.
  • FIG. 1 is a schematic view showing the structure of a medical device of the present invention.
  • Figure 2 is an enlarged view of A in Figure 1.
  • FIG. 3 is a schematic view showing the film of the medical device of FIG. 1 partially cut away.
  • FIG. 4 is a schematic view of the metal lumen stent of FIG. 3.
  • FIG. 5 is a partial schematic view of a flow blocking film according to another embodiment of the present invention.
  • FIG. 6 is a schematic diagram of a flow blocking film according to still another embodiment of the present invention.
  • FIG. 7 is a schematic diagram of a flow blocking film according to still another embodiment of the present invention.
  • the interventional medical device of the present invention is exemplified by a mitral valve artificial heart valve, and the inventive concept can also be applied to an artificial blood vessel stent, a left atrial appendage occluder, and a congenital heart defect occluder. And other interventional medical devices.
  • the heart valve tissue according to the present invention refers to any one of heart tissue such as an annulus, a leaflet, a chordae, and a papillary muscle, or a combination of several tissues.
  • the interventional medical device 100 of the present embodiment includes a covered lumen stent 10 and a leaflet 20 disposed in the lumen of the stented stent 10.
  • the stented stent 10 is a hollow tubular structure comprising a metal lumen stent 11 and a baffle film 12 disposed on the inner wall of the metal lumen stent 11.
  • the stented stent 10 in this embodiment is the main body frame of the prosthetic valve. After the at least two closable flaps 20 are disposed in the lumen of the stented stent 10, the interventional medical device 100 is formed, that is, artificial. Heart valve.
  • the artificial valve is radially compressed and implanted into the damaged valve of the human body via a catheter to replace the damaged valve to realize the physiological function of the damaged valve.
  • the stented stent 10 can also be part of a medical device or a medical device implanted in a human body.
  • the stented stent 10 can also be a vascular stent for treating a hemangioma.
  • the metal lumen stent 11 is a support body of the stented stent 10 for expanding the stented stent 10 and adhering to the wall of the human body.
  • the metal lumen support 11 has a hollow tubular shape and includes a plurality of corrugated rings, and the metal lumen support 11 has an integral structure.
  • the "integral structure" in the present invention means that the metal lumen support 11 is formed by laser cutting and heat setting of a metal tube, or the metal lumen support 11 is composed of a plurality of components fixedly connected, such as a metal lumen support 11 Two components are welded to form. a plurality of hollows 111 are provided on the side of the metal lumen support 11 to make the metal lumen support 11 The side is hollowed out.
  • the metal lumen support 11 is made of a metal material having superelasticity or shape memory function, such as Nitinol, Nitinol, Nitinol or an alloy thereof.
  • the metal lumen support 11 is cut by a nickel-titanium tube, and the outer diameter of the nickel-titanium tube is preferably 5 mm to 12 mm, and the wall thickness of the nickel-titanium tube is preferably 0.2 mm to 0.6 mm.
  • the plurality of hollows are cut by laser on the nickel-titanium tube; then, the cut nickel-titanium tube is expanded under heat treatment conditions to a diameter suitable for a human damaged valve to obtain a metal lumen support 11
  • the metal lumen support 11 can also be woven with nickel-titanium wire.
  • the metal lumen support 11 can also be composed of a plurality of separate components. At this time, the metal lumen support 11 is no longer an integral structure.
  • the metal lumen support 11 can be composed of a plurality of separated metal wave-shaped annular structures. Aligning the axes of the plurality of separate metal-wave-shaped annular structures and sequentially arranging them along the axis, for example, by a soldering process or by connecting two adjacent metal-wave-shaped annular structures with a connecting member The metal corrugated annular structure is combined to form a hollow tubular metal lumen support 11 at which time each of the metal rings may include the hollow, or each two adjacent metal corrugated annular structures may cooperate to form the Hollowed out.
  • the stented stent 10 includes an inner membrane body 13 covering the inner surface of the metal lumen stent 11, an outer membrane body 15 covering the outer surface of the metal lumen stent 11, and an inner membrane.
  • the surface of the inner film body 13 is provided with a reinforcing region having the same shape and size as the outer surface, the reinforcing mesh 17 is located in the reinforcing region, and covers the inner surface of the metal lumen support 11, the inner film body 13 and the reinforcement
  • the mesh 17 constitutes the flow blocking film 12.
  • the inner film body 13 and the reinforcing mesh 17 may be first formed into a whole body, that is, a baffle film, and then fixed to the metal tube by a conventional process such as stitching, bonding or thermocompression bonding.
  • the inner surface of the cavity holder 11; the reinforcing mesh 17 may be directly covered to the inner surface of the metal lumen support 11, the inner film body 13 is covered on the reinforcing mesh 17, and the outer film body 15 is covered on the metal lumen support.
  • the outer surface of the elbow 11 is then fixed to the metal lumen support 11 by a hot press synthesis.
  • the inner film body 13, the outer film body 15, and the reinforcing mesh 17 are integrally joined to each other at the hollow portion 111 of the metal lumen support 11. It can be understood that in other embodiments, the metal lumen support 11, the inner film body 13, the outer film body 15 and the reinforcing mesh 17 may also be bonded together by an adhesive or stitched by suture stitching. As one.
  • the inner membrane body 13 and the outer membrane body 15 are used to form the stent lumen 10 to form a side-sealed lumen, so that blood flow only flows through the lumen of the stented stent 10 without covering the membrane
  • the side of the lumen support 10 seeps out.
  • the thickness of the inner film body 13 and the outer film body 15 may be between 0.01 and 0.06 mm, and the sum of the thicknesses of the inner film body 13, the outer film body 15 and the reinforcing layer, that is, the thickness of the flow blocking film is 0.06.
  • the inner membrane body 13 and the outer membrane body 15 can also effectively prevent blood from flowing from the inside of the stent lumen stent 10
  • the thickness of the inner film body 13 and the outer film body 15 are both 0.01 mm
  • the inner film body 13 and the outer film body 15 are both ePTFE (expanded polytetrafluoroethylene).
  • the inner film body 13 and the outer film body 15 are respectively coated on the inner and outer surfaces of the metal lumen support 11, thereby reducing the possibility of metal ion release from the metal lumen support 11, and reducing the metal lumen support.
  • the possibility of surface oxide layer detachment of 11 ensures the safety of the stented stent 10 after implantation into the body.
  • the inner film body 13 and the outer film body 15 may also each be formed by superposing a plurality of layers of ePTFE single layer film, thereby forming two sets of opposing films.
  • the reinforcing mesh 17 is formed by staggering a plurality of reinforcing members having a mesh number ranging from 50 mesh to 120 mesh.
  • the plurality of reinforcing members may be arranged in a staggered arrangement in which the two sets of reinforcing members are vertically intersected to form a "ten" word mesh structure or a "ten” structure having no mesh, or directly formed on a large reinforcing cloth.
  • Each set of reinforcements includes a plurality of mutually parallel reinforcements.
  • the reinforcing mesh may be a knitted mesh or a woven mesh having a thickness ranging from 0.1 mm to 0.6 mm.
  • the reinforcing member can be made of a polymer material such as PTFE, PET or ultra high molecular weight polyethylene.
  • the reinforcing member is a wire-like structure having a circular cross section or a strip-shaped structure having a flat cross section, and the diameter or the maximum sectional size preferably ranges from 0.05 mm to 0.6 mm.
  • the diameter of the reinforcing wire or the maximum cross-sectional dimension of the reinforcing mesh 17 is less than 0.05 mm, the toughness and strength of the reinforcing mesh 17 may be poor, and the tear resistance and the anti-scratching ability are poor, when the laminar stent is implanted After entering the body, the baffle 12 may still be damaged by blood flow or by the suture; when the diameter or maximum cross-sectional dimension of the mesh of the reinforcing mesh 17 is greater than 0.6 mm, the radial compression of the stent graft 10 The size is significantly increased, so that the stent graft 10 can not be loaded into the delivery catheter with a smaller inner diameter after being radially compressed, so that it cannot be implanted into the body through a delivery catheter having a smaller inner diameter, or the stented stent 10 is in the delivery catheter.
  • the reinforcing mesh 17 forms a tubular structure around the metal lumen support 11; the reinforcing mesh 17 is made of PTFE Made of (polytetrafluoroethylene), and the reinforcing member (i.e., the mesh) of the reinforcing net 17 has a diameter of 0.3 mm; the plurality of meshes of the reinforcing net 17 have the same size and shape.
  • the staggered network wires in the baffle film 12 can not only improve the toughness and strength of the baffle film 12, but also prevent the suture film 12 from being sutured when sutured through the mesh through the mesh to the metal lumen stent.
  • the reinforcing net 17 has a plurality of meshes, a plurality of mesh lines surrounding the mesh, and a plurality of bumps formed by intersections of the two intersecting mesh lines (ie, intersections of two lines in the "ten" structure), when enhanced
  • the net 17 is located on the surface of the membrane body, the roughness of the obstruction membrane 12 can be increased, the friction between the stent lumen 10 and the lumen wall of the stent can be increased, and the stent lumen 10 can be reduced in the lumen. The risk of shifting.
  • the inner film body 13, the outer film body 15 and the reinforcing mesh 17 are bonded together, so that the choke film 12 and the choke film 12 are filled in the hollow portion 1111.
  • the mesh of the inner reinforcing mesh 17 becomes an obstacle for blocking the movement of the metal lumen support 11 in the choke film 12, thereby preventing the risk of the metal lumen support 11 moving in the choke film 12, and the choke film 12 is improved.
  • the bonding strength with the metal lumen stent 11 reduces the risk of the choke membrane 12 falling off the metal lumen stent 11 after implantation in the human body.
  • the reinforcing mesh 17 has a mesh hole for allowing blood to pass through; if blood is infiltrated somewhere in the inner film body 13, the blood can be dispersed in the mesh, thereby preventing blood from being concentrated in the blood infiltration, reducing the blood.
  • the pressure at the blood infiltration of the inner membrane body 13 prevents the cracks in the blood infiltration of the inner membrane body 13 from continuing to expand, prolonging the service life of the stent lumen stent 10.
  • the distance between the two most distant points on any of the meshes of the reinforcing mesh 17 is less than the distance between the two most distant points on the annular structure 112 having the smallest area of the metal lumen support 11. . That is, each cutout corresponds to at least a portion of the reinforcing mesh, such as at least one mesh structure. As such, when it is desired to suture the leaflets at the hollow 111 of the metal lumen support 11, the reinforcing mesh 17 can better and more effectively improve the tear resistance and puncturing resistance of the flow blocking film 12.
  • the leaflet 20 in this embodiment can be connected to the stented stent 10 by suture through the mesh through the mesh; since the choke membrane 12 of the stented stent 10 has a mesh line therein,
  • the leaflet 20 is sewn to the stented stent 10 through the needle with the suture attached, since the tensile strength of the reinforcing member itself is higher than the tensile strength of the membrane body, the needle is not easily drawn on the blocking membrane 12
  • the large through hole, and the reinforcement forming the mesh restricts the sliding of the suture, reducing the wind that the leaflet 20 falls off the laminar lumen support 10. The risk extends the life of the medical device 100.
  • the reinforcing mesh 17 can also be disposed between the outer film body 15 and the inner film body 13 piece by piece according to actual needs, and needs to improve tear resistance and anti-hole drilling performance. position. It will also be appreciated that in other embodiments, the reinforcement of the reinforcing mesh 17 may also be in the form of a flat strip. It can also be understood that in other embodiments, the cross section of the filament-shaped reinforcing member may also have other shapes such as a triangle, a quadrangle, a pentagon or the like.
  • the baffle film 12 can be covered on the outer surface of the lumen stent 11, and the outer membrane body 15 in this embodiment is placed on the tube.
  • the edge of the choke film 12 is also stitched by a wire.
  • the flow blocking film 12 includes a film body and a reinforcement located in the reinforcing region of the film body, and the reinforcing region may be located at the edge of the film body It is also possible to match the shape and size of the film body, that is, the reinforcing layer may be provided only at the edge of the film body, or the reinforcing layer may be provided on the entire surface of the film body.
  • the choke film 12 Since the choke film 12 has a mesh line, when the choke film 12 is sewn into the inside of the occluder by a needle connected with a suture, the needle or the suture is difficult to draw a large through hole on the choke film 12, The risk of the choke film 12 falling off the occluder is reduced, and the life of the occluder is prolonged.
  • the inside of the choke film 12 has a mesh line, and the toughness and strength of the choke film 12 are also strong, and it is not easily torn under the impact of blood flow, thereby improving the plugging effect and service life of the occluder.
  • the reinforcing member may be disposed on the surface of the film body in other forms.
  • the reinforcing member may have only one piece, which is annularly disposed on the edge portion of the film body or is threaded.
  • the pattern is disposed on the surface of the film body, or is woven by the root reinforcement to form a mesh having a plurality of meshes.
  • a flow blocking film 12a includes an outer film body 15a and a reinforcing mesh 17a provided in the outer film body 15a.
  • the outer film body 15a includes an inner sub-layer 151a and an outer sub-layer 153a, and the two opposite surfaces of the inner sub-layer 151a and the outer sub-layer 153a are provided with reinforcing regions having shapes and sizes matching the two surfaces.
  • the reinforcing mesh 17a is disposed between the inner sub-layer 151a and the outer sub-layer 153a and located in the enhanced region.
  • the reinforcing mesh 17a is preliminarily disposed between the inner sub-layer 151a and the outer sub-layer 153a by means of hot pressing.
  • the reinforcing mesh 17a and the outer layer There is a strong bonding force between the film bodies 15a, and it is difficult for the reinforcing mesh 17a to be detached from the outer film body 15a.
  • the implanted medical device further has the inner layer membrane body as described in the first embodiment, and the implanted medical device comprises a metal lumen stent
  • the outer membrane body 15a having the reinforcing mesh 17a can be further subjected to hot pressing
  • the method and the inner membrane body are respectively disposed on the outer surface and the inner surface of the lumen support, and are combined at the hollowed out portion.
  • the reinforcing mesh 17a is subjected to two hot pressing processes and the inner film body and the outer film body. Bonding makes it more difficult to detach from the inner film body and the outer film body.
  • the baffle film 12a can be directly placed inside the occluder, and the reinforcing layer located at the edge region thereof is directly connected to the occluding body.
  • the stented stent 10b of the third embodiment of the present invention is substantially the same as the stented stent 10, and includes a metal lumen stent 11b and a baffle film 12b disposed on the metal lumen stent 11b.
  • the covered lumen stent 10b is different from the stented stent 10 in that the membrane 12b includes an inner membrane body 13b disposed on the inner surface of the metal lumen stent 11b, and is disposed on the outer surface of the metal lumen stent 11b.
  • the surface of the outer film body 15b is covered with a reinforcing member 17b, and the reinforcing member 17b and the outer layer film body 15b constitute a flow blocking film.
  • the reinforcing member 17b may be made of PTFE (polytetrafluoroethylene), PET (polyethylene terephthalate), PE (polyethylene), nylon, glass fiber, carbon fiber, ultra high molecular weight polyethylene or stainless steel. Its diameter ranges from 0.05 mm to 0.6 mm.
  • the reinforcing member 17b is a wire-like structure having a circular cross section; each reinforcing member 17b forms an annular structure surrounding the metal lumen bracket 11b, and the plurality of reinforcing members 17b are parallel to each other; adjacent The distance between the two reinforcing members 17b in the axial direction of the metal lumen bracket 11b is smaller than the distance between the two most distant points on the annular structure having the smallest area of the metal lumen bracket 11b.
  • the reinforcing member 17b can improve the overall tear resistance and puncturing resistance of the film body composed of the inner film body 13b and the outer film body 15b.
  • the plurality of reinforcing members 17b can not only improve the toughness and strength of the outer layer membrane body 15b, but also block the suture needle from drawing a large hole in the choke membrane, and the reinforcing member can not only improve the tear resistance of the choke membrane, but also The anti-cratering ability of the choke film can be improved.
  • the plurality of reinforcing members 17b are parallel to each other and have a gap between the adjacent two reinforcing members 17b, so that the roughness of the choke film can be increased, and the laminar lumen stent 10b and the lumen wall of the implantation can be improved. Friction between the lowering of the stent lumen 10b in the lumen The risk of internal shifting.
  • the inner film body 13b, the outer layer film body 15b and the reinforcing member 17b are bonded together, so that the choke film and the choke film filled in the hollow portion 111b are
  • the mesh of the reinforcing member 17b acts as an obstacle to block the movement of the metal lumen support 11b in the choke membrane, thereby preventing the risk of the metal lumen support 11b moving within the choke membrane, and improving the choke membrane and the metal lumen stent.
  • the bonding strength between 11b reduces the risk of the choke film falling off the metal lumen stent 11b after implantation in the human body.
  • some of the plurality of reinforcing members 17b are parallel to each other, and the remaining reinforcing members are alternately arranged to form a mesh structure having a mesh or a "ten" reinforcing pad structure having no mesh.
  • a portion of the plurality of reinforcing members 17b has an annular structure, and the remaining reinforcing members have a longitudinal direction parallel to the axial direction of the metal lumen support 11b.
  • the stented stent holder 10c according to the fourth embodiment of the present invention is substantially the same as the stented stent stent 10b, except that the plurality of reinforcing members 17c of the stented stent stent 10c are staggered.
  • Forming a reinforcing mesh having a plurality of meshes having different sizes and shapes, and the distance between the two points farthest from each of the meshes is smaller than the distance between the hollows 112c having the smallest area of the metal lumen support 11c The distance between the two points.
  • the staggered reinforcing members 17c can improve the tear resistance and the puncturing resistance of the film in multiple directions.
  • the reinforcing member not only improves the tear resistance of the choke film, but also improves the anti-cratering ability of the choke film.
  • the reinforcing net has a plurality of meshes, a plurality of mesh wires surrounding the mesh holes, and a plurality of bumps formed by intersections of the two intersecting mesh wires, so that the roughness of the choke film having the reinforcing mesh can be increased, and the The friction between the stented stent of the baffle and the wall of the lumen of the implant reduces the risk of displacement of the stented stent with the baffle in the lumen.
  • the inner membrane body, the outer membrane body and the reinforcing mesh are bonded together, so that the choke membrane and the resistance filled in the hollow portion are blocked.
  • the mesh of the reinforcing mesh in the flow film becomes an obstacle to block the movement of the metal lumen bracket in the choke membrane, thereby preventing the risk of the metal lumen stent moving in the choke membrane, and improving the choke membrane and the metal lumen.
  • the strength of the bond between the stents reduces the risk of the choke membrane falling off the metal lumen stent after implantation in the human body.
  • the reinforcing mesh has a mesh to allow blood to pass through; if blood is infiltrated in a certain part of the inner film body, the blood can be dispersed in the mesh, thereby preventing blood from being concentrated in the blood infiltration and reducing the inside.
  • the pressure at the place where the blood is infiltrated into the film body prevents the crack of the blood infiltration portion of the inner film body from continuing to expand, prolonging the service life of the film tube stent having the flow blocking film.

Abstract

Disclosed are a flow blocking membrane (12, 12a, 12b) and a medical device (100) comprising the flow blocking membrane (12, 12a, 12b). The flow blocking membrane (12, 12a, 12b) comprises a membrane body (13, 15a, 13b, 15b) and an enhancement layer (17, 17a, 17b, 17c) arranged on the surface of the membrane body or inside the membrane body, with the tensile strength of the enhancement layer (17, 17a, 17b, 17c) being greater than the tensile strength of the membrane body (13, 15a, 13b, 15b). The enhancement layer (17, 17a, 17b, 17c) can prevent a needle or a suture from scratching the flow blocking membrane (12, 12a, 12b) to form a large hole, thereby improving the suturing strength and healing rate of the flow blocking membrane (12, 12a, 12b).

Description

阻流膜及植入医疗器械Resisting membrane and implanted medical device 技术领域Technical field
本发明涉及植入医疗器械技术领域,尤其涉及一种阻流膜及具有该阻流膜的植入医疗器械。The invention relates to the field of implanted medical device technology, in particular to a flow blocking film and an implanted medical device having the same.
背景技术Background technique
随着介入医疗器械和介入手术方式的不断发展,经导管植入各种封堵器、人工血管支架及人工瓣膜等医疗器械已经成为治疗瓣膜病、血管瘤和血管狭窄、及先天性心脏缺损的重要方法。With the continuous development of interventional medical devices and interventional procedures, transcatheter implantation of various occluders, artificial vascular stents and prosthetic valves and other medical devices has become a treatment for valvular disease, hemangioma and vascular stenosis, and congenital heart defects. Important method.
常见的治疗先天性心脏缺损如房间隔缺损、室间隔缺损和卵圆孔未闭的封堵器一般包括左盘、右盘、连接左盘和右盘的腰部及设置于两盘和/或腰部中的以增加封堵效果的阻流膜。动脉导管未闭封堵器包括盘状结构和柱状腰部以及设于盘状结构和/或柱状腰部内的阻流膜。分体式左心耳封堵器通常包括封堵盘和用于植入左心耳腔内将封堵盘固定在左心耳口部的固定架,以及设于封堵盘内的阻流膜。所述阻流膜可由聚酯纤维制成,用于增强封堵效果。Common occluder devices for the treatment of congenital heart defects such as atrial septal defect, ventricular septal defect and patent foramen ovale generally include the left and right discs, the waist connecting the left and right discs, and the two discs and/or the waist. A choke film to increase the plugging effect. The patent ductus arteriosus occluder includes a disc-like structure and a columnar waist and a baffle film disposed in the disc-like structure and/or the columnar waist. The split left atrial appendage occluder generally includes a occlusion disk and a fixing frame for implanting the occlusion disk in the left atrial appendage in the left atrial appendage, and a choke membrane disposed in the occlusion disk. The flow-blocking film may be made of polyester fiber for enhancing the plugging effect.
人工瓣膜和人工血管支架均包括覆膜支架,所述覆膜支架一般包括金属裸支架和覆盖于所述金属支架上的由聚四氟乙烯膜制成的阻流膜。上述的阻流膜的力学强度比较低,尤其是制作人工瓣膜时,若采用缝合工艺将瓣叶缝合到金属裸支架上的阻流膜上,该阻流膜容易被缝线划出较大的孔,导致难以将阻流膜固定在金属裸支架上,缝合良率较低。并且包括该阻流膜的植入医疗器械诸如先天性心脏缺损封堵器、左心耳封堵器、人工瓣膜和人工血管支架植入人体后,在血流的不断冲击下,阻流膜在缝合处容易撕裂,撕裂的阻流膜易从支架或者封堵器上脱落,缩短了医疗器械的使用寿命。Both the prosthetic valve and the artificial blood vessel stent comprise a stent graft, and the stent graft generally comprises a bare metal stent and a flow blocking membrane made of a polytetrafluoroethylene membrane covering the metal stent. The mechanical strength of the above-mentioned baffle film is relatively low, especially when a prosthetic valve is fabricated, if the leaflet is sutured to the choke film on the bare metal support by a stitching process, the choke film is easily drawn by the suture. The hole makes it difficult to fix the choke film on the bare metal bracket, and the stitching yield is low. And the implanted medical device including the choke membrane, such as a congenital heart defect occluder, a left atrial appendage occluder, a prosthetic valve and an artificial blood vessel stent, are implanted in the human body, and the spoiler is sutured under the continuous impact of blood flow. It is easy to tear, and the tearing choke film easily falls off the stent or the occluder, shortening the service life of the medical device.
发明内容Summary of the invention
基于此,有必要提供一种不易撕裂的阻流膜及一种具有该阻流膜的植入医 疗器械,以提高植入医疗器械的使用寿命。Based on this, it is necessary to provide a barrier film that is not easy to tear and an implant doctor having the barrier film. Therapeutic devices to increase the life of implanted medical devices.
本技术方案提供的阻流膜是在现有阻流膜上增加增强层,其包括设有增强区的膜本体以及设于所述增强区内的增强层。所述增强层的抗拉强度大于所述膜本体的抗拉强度。所述增强区可以设于所述膜本体的表面,即在膜本体的表面上设置增强层。当膜本体包括两组相对的膜时,增强区可设于所述两组膜相对的表面,所述阻流膜夹设于所述两组膜之间,即将增强层设于膜本体的内部。The flow blocking film provided by the technical solution is to add a reinforcing layer on the existing flow blocking film, which comprises a film body provided with a reinforcing region and a reinforcing layer disposed in the reinforcing region. The tensile strength of the reinforcing layer is greater than the tensile strength of the film body. The reinforcing region may be provided on a surface of the film body, that is, a reinforcing layer is provided on a surface of the film body. When the film body comprises two sets of opposite films, the reinforcing regions may be disposed on opposite surfaces of the two sets of films, and the baffle film is sandwiched between the two sets of films, that is, the reinforcing layer is disposed inside the film body .
增强层可与膜本体具有相同的形状和尺寸,也可根据实际需要在膜本体的局部区域设置增强层。例如,增强区可以位于阻流膜的边缘,作为举例,对用于先天性心脏缺损封堵器或分体式左心耳封堵器内的阻流膜而言,阻流膜可呈圆形,增强区可为设于阻流膜边缘的环形区域,对于覆膜管腔支架而言,阻流膜可为与所述管腔支架本体具有相同形状及尺寸的圆柱形,即阻流膜完全与覆膜管腔支架的内表面或外表面重合。The reinforcing layer may have the same shape and size as the film body, and a reinforcing layer may be disposed in a partial region of the film body according to actual needs. For example, the enhancement zone can be located at the edge of the baffle, by way of example, for a choke membrane in a congenital heart defect occluder or a split left atrial appendage occluder, the baffle can be rounded and reinforced The zone may be an annular region disposed at the edge of the baffle membrane. For the stented stent, the barrier film may have a cylindrical shape having the same shape and size as the lumen stent body, that is, the barrier film is completely covered and covered. The inner or outer surface of the membranous lumen stent coincides.
阻流膜内的增强层可以包括多根增强件,所述多根增强件交错排布形成具有十字结构的增强网;或所有所述增强件相互平行;或所述多根增强件中的一部分增强件交错排布形成具有十字结构的增强网,另一部分增强件相互平行。所述增强网指各十字结构之间形成有网孔的网状结构,也可指十字结构紧密排布而没有网孔的结构。所述增强件的抗拉强度大于所述膜本体的抗拉强度。The reinforcing layer in the baffle film may include a plurality of reinforcing members staggered to form a reinforcing mesh having a cross structure; or all of the reinforcing members are parallel to each other; or a part of the plurality of reinforcing members The reinforcing members are staggered to form a reinforcing mesh having a cross structure, and the other portions of the reinforcing members are parallel to each other. The reinforcing mesh refers to a mesh structure in which meshes are formed between the cross structures, and may also refer to a structure in which the cross structures are closely arranged without meshes. The tensile strength of the reinforcement is greater than the tensile strength of the film body.
所述增强网的目数范围为50目至120目。所述增强件的直径范围为0.05毫米至0.6毫米。所述阻流膜的厚度范围为0.06毫米至0.72毫米。The mesh of the reinforcing mesh ranges from 50 mesh to 120 mesh. The reinforcement has a diameter ranging from 0.05 mm to 0.6 mm. The thickness of the baffle film ranges from 0.06 mm to 0.72 mm.
本技术方案还包括提供一种植入医疗器械,包括器械本体和前述的阻流膜,其中阻流膜的设有所述增强层的部分与所述器械本体相连。The technical solution further includes providing an implantable medical device comprising the instrument body and the aforementioned flow blocking film, wherein a portion of the baffle film provided with the reinforcing layer is coupled to the instrument body.
所述器械本体可为先天性心脏缺损封堵器和左心耳封堵器等具有网状封堵盘的器械。所述阻流膜位于封堵盘内,增强层位于阻流膜的边缘,增强层缝合在封堵盘上。The instrument body may be a device having a mesh-shaped plug disk such as a congenital heart defect occluder and a left atrial appendage occluder. The baffle film is located in the occlusion disk, the reinforcement layer is located at the edge of the baffle film, and the reinforcement layer is sewn on the occlusion disk.
所述器械本体也可为包括具有多个波形环状结构的管腔支架,所述管腔支架在至少两个相邻的波形环状结构之间具有镂空,所述阻流膜可覆盖所述管腔支架的至少一个表面,如内表面或外表面,或同时覆盖内表面和外表面,或可覆盖前述表面的全部区域或只覆盖内表面或外表面的部分区域,即未被覆盖的 表面会暴露出部分镂空,对应地,管腔支架被覆盖的表面的镂空被阻流膜覆盖。The instrument body may also include a lumen stent having a plurality of corrugated annular structures, the lumen stent having a hollow between at least two adjacent corrugated annular structures, the obturator membrane covering the At least one surface of the lumen support, such as an inner or outer surface, or both inner and outer surfaces, or may cover all of the aforementioned surface or only a portion of the inner or outer surface, ie, uncovered The surface is exposed to a partial hollow, and correspondingly, the hollow of the covered surface of the lumen support is covered by the choke film.
当所述增强件形成所述增强网时,所述增强网的任一网孔上相距最远的两点之间的距离,小于面积最小的所述环状结构上的相距最远的两点之间的距离,即至少一个被阻流膜覆盖的镂空对应的那部分阻流膜里含有部分增强层。When the reinforcing member forms the reinforcing mesh, a distance between two points farthest from each other on the mesh of the reinforcing mesh is smaller than two farthest points on the annular structure having the smallest area The distance between the at least one portion of the baffle film corresponding to the hollow covered by the baffle film contains a portion of the reinforcing layer.
当阻流膜只覆盖覆膜管腔支架的一表面例如腔体的内表面时,所述管腔支架还可以包括覆盖所述管腔支架的另一表面即外表面的覆膜,该覆膜在镂空处与所述阻流膜相连。When the choke membrane covers only one surface of the stent lumen stent, such as the inner surface of the cavity, the lumen stent may further include a membrane covering the other surface of the lumen stent, that is, the outer surface, the membrane It is connected to the choke film at the hollow.
当所述器械本体为人工瓣膜时,其还包括瓣叶,所述阻流膜覆盖所述管腔支架的内表面或外表面,所述瓣叶设于所述管腔支架的腔内,并在镂空处与所述阻流膜内的增强层相连。When the instrument body is a prosthetic valve, it further includes a leaflet covering the inner surface or the outer surface of the lumen stent, the leaflet being disposed in the lumen of the lumen stent, and Connected to the reinforcement layer in the baffle at the hollow.
本发明的阻流膜包括抗拉强度比膜本体的抗拉强度高的增强件。当各增强件相互配合形成网孔时,可将缝线直接穿过网孔而将阻流膜在器械本体的镂空处缝合到器械本体上,例如将阻流膜的边缘缝合到先天性心脏缺损封堵器的网状封堵盘上;或者可先将阻流膜覆盖在具有镂空的器械本体例如血管支架上,并让增强层对应地位于器械本体的镂空处,然后将其他元件通过缝线缝合到阻流膜的增强层上,例如将瓣叶缝合到人工瓣膜支架内壁的阻流膜上。增强件能限制缝线滑动,即使增强层未有网孔,缝线穿过增强层时也会因为增强件自身的抗拉强度而被限制滑动,由此避免阻流膜被缝线划出较大开口,从而提高缝合良率和缝合处的抗拉强度。The flow blocking film of the present invention includes a reinforcing member having a tensile strength higher than that of the film body. When the reinforcing members cooperate with each other to form a mesh, the suture can be directly passed through the mesh to suture the choke film to the instrument body at the hollow of the instrument body, for example, suturing the edge of the choke membrane to the congenital heart defect. The mesh of the occluder is closed on the disc; or the choke film may be first covered on the instrument body having a hollow, such as a blood vessel support, and the reinforcement layer is correspondingly located at the hollow of the instrument body, and then the other components are passed through the suture Stitching onto the reinforcing layer of the baffle, such as suturing the leaflets to the baffle of the inner wall of the prosthetic valve stent. The reinforcing member can restrict the suture sliding. Even if the reinforcing layer has no mesh, the suture passes through the reinforcing layer and is restricted from sliding due to the tensile strength of the reinforcing member itself, thereby preventing the chordal film from being drawn by the suture. Large openings to increase stitching yield and tensile strength at the seam.
附图说明DRAWINGS
图1为本发明的医疗器械的结构示意图。1 is a schematic view showing the structure of a medical device of the present invention.
图2为图1中的A处的放大图。Figure 2 is an enlarged view of A in Figure 1.
图3为图1中的医疗器械的覆膜被部分剖开后的示意图。3 is a schematic view showing the film of the medical device of FIG. 1 partially cut away.
图4为图3中的金属管腔支架的示意图。4 is a schematic view of the metal lumen stent of FIG. 3.
图5为本发明另一实施例提供的阻流膜的部分示意图。FIG. 5 is a partial schematic view of a flow blocking film according to another embodiment of the present invention.
图6为本发明再一实施例提供的阻流膜的示意图。FIG. 6 is a schematic diagram of a flow blocking film according to still another embodiment of the present invention.
图7为本发明又一实施例提供的阻流膜的示意图。 FIG. 7 is a schematic diagram of a flow blocking film according to still another embodiment of the present invention.
具体实施方式detailed description
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。The present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It is understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
需要说明的是,本发明的介入医疗器械以二尖瓣的人工心脏瓣膜为例进行说明,而本发明的构思还可以用在人工血管支架、左心耳封堵器、先天性心脏缺损封堵器等介入医疗器械。还需要说明的是,本发明所涉及的心脏瓣膜组织是指瓣环、瓣叶、腱索、乳头肌等心脏组织中的任一种或者几种组织的组合。It should be noted that the interventional medical device of the present invention is exemplified by a mitral valve artificial heart valve, and the inventive concept can also be applied to an artificial blood vessel stent, a left atrial appendage occluder, and a congenital heart defect occluder. And other interventional medical devices. It should be noted that the heart valve tissue according to the present invention refers to any one of heart tissue such as an annulus, a leaflet, a chordae, and a papillary muscle, or a combination of several tissues.
除非另有定义,本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文中在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。本文所使用的术语“及/或”包括一个或多个相关的所列项目的任意的和所有的组合。All technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs, unless otherwise defined. The terminology used in the description of the present invention is for the purpose of describing particular embodiments and is not intended to limit the invention. The term "and/or" used herein includes any and all combinations of one or more of the associated listed items.
请一并参阅图1至图3,本实施例中的介入医疗器械100包括覆膜管腔支架10及设于覆膜管腔支架10管腔内的瓣叶20。覆膜管腔支架10为中空管状结构,包括金属管腔支架11及设于金属管腔支架11内壁上的阻流膜12。本实施例中的覆膜管腔支架10为人工瓣膜的主体框架,在覆膜管腔支架10的管腔内设置至少两个可闭合的瓣叶20后,即形成介入医疗器械100,即人工心脏瓣膜。所述人工瓣膜被径向压缩后可经导管植入人体受损瓣膜中,替代所述受损瓣膜,实现所述受损瓣膜的生理功能。可以理解,覆膜管腔支架10还可以为其他植入人体内的医疗器械或医疗器械的部分结构,比如,覆膜管腔支架10还可以为治疗血管瘤的血管支架。Referring to FIG. 1 to FIG. 3 together, the interventional medical device 100 of the present embodiment includes a covered lumen stent 10 and a leaflet 20 disposed in the lumen of the stented stent 10. The stented stent 10 is a hollow tubular structure comprising a metal lumen stent 11 and a baffle film 12 disposed on the inner wall of the metal lumen stent 11. The stented stent 10 in this embodiment is the main body frame of the prosthetic valve. After the at least two closable flaps 20 are disposed in the lumen of the stented stent 10, the interventional medical device 100 is formed, that is, artificial. Heart valve. The artificial valve is radially compressed and implanted into the damaged valve of the human body via a catheter to replace the damaged valve to realize the physiological function of the damaged valve. It can be understood that the stented stent 10 can also be part of a medical device or a medical device implanted in a human body. For example, the stented stent 10 can also be a vascular stent for treating a hemangioma.
请参阅图4,金属管腔支架11为覆膜管腔支架10的支撑主体,用于使覆膜管腔支架10植入体内后膨胀并且贴紧人体管腔壁。金属管腔支架11呈中空管状,包括多个波形环状物,且金属管腔支架11为一体结构。本发明中的所述“一体结构”是指金属管腔支架11由一个金属管激光切割且热定型后形成,或者金属管腔支架11由多个元件固定连接组成,比如金属管腔支架11由两个元件焊接形成。金属管腔支架11的侧面上设有多个镂空111,以使金属管腔支架11的 侧面呈镂空网状。Referring to FIG. 4, the metal lumen stent 11 is a support body of the stented stent 10 for expanding the stented stent 10 and adhering to the wall of the human body. The metal lumen support 11 has a hollow tubular shape and includes a plurality of corrugated rings, and the metal lumen support 11 has an integral structure. The "integral structure" in the present invention means that the metal lumen support 11 is formed by laser cutting and heat setting of a metal tube, or the metal lumen support 11 is composed of a plurality of components fixedly connected, such as a metal lumen support 11 Two components are welded to form. a plurality of hollows 111 are provided on the side of the metal lumen support 11 to make the metal lumen support 11 The side is hollowed out.
金属管腔支架11采用超弹性或具有形状记忆功能的金属材料制成,比如镍钛诺、镍钛钴、镍钛或其合金。本发明中,金属管腔支架11采用镍钛管切割而成,所述镍钛管的外径优选为5mm-12mm,所述镍钛管的壁厚优选为0.2mm-0.6mm。首先,在所述镍钛管上利用激光切割出所述多个镂空;然后,将切割后的所述镍钛管在热处理条件下扩张到适合人体受损瓣膜的直径,得到金属管腔支架11,本发明中,优选将所述镍钛管的外径扩张到25mm-35mm。可以理解,金属管腔支架11还可以采用镍钛丝编织而成。The metal lumen support 11 is made of a metal material having superelasticity or shape memory function, such as Nitinol, Nitinol, Nitinol or an alloy thereof. In the present invention, the metal lumen support 11 is cut by a nickel-titanium tube, and the outer diameter of the nickel-titanium tube is preferably 5 mm to 12 mm, and the wall thickness of the nickel-titanium tube is preferably 0.2 mm to 0.6 mm. First, the plurality of hollows are cut by laser on the nickel-titanium tube; then, the cut nickel-titanium tube is expanded under heat treatment conditions to a diameter suitable for a human damaged valve to obtain a metal lumen support 11 In the present invention, it is preferred to expand the outer diameter of the nickel-titanium tube to 25 mm to 35 mm. It can be understood that the metal lumen support 11 can also be woven with nickel-titanium wire.
可以理解,金属管腔支架11也可以由多个分离的元件组成,此时金属管腔支架11不再为一体结构,比如金属管腔支架11可以由多个分离的金属波形环状结构组成,将所述多个分离的金属波形环状结构的轴线重合设置,并沿轴线依次排列,例如通过焊接工艺或采用连接件连接相邻的两个金属波形环状结构而使所述多个分离的金属波形环状结构组合形成中空管状的金属管腔支架11,此时,每个所述金属环中可以包括所述镂空,或者每两个相邻的金属波形环状结构之间配合形成所述镂空。It can be understood that the metal lumen support 11 can also be composed of a plurality of separate components. At this time, the metal lumen support 11 is no longer an integral structure. For example, the metal lumen support 11 can be composed of a plurality of separated metal wave-shaped annular structures. Aligning the axes of the plurality of separate metal-wave-shaped annular structures and sequentially arranging them along the axis, for example, by a soldering process or by connecting two adjacent metal-wave-shaped annular structures with a connecting member The metal corrugated annular structure is combined to form a hollow tubular metal lumen support 11 at which time each of the metal rings may include the hollow, or each two adjacent metal corrugated annular structures may cooperate to form the Hollowed out.
请再次参阅图3,覆膜管腔支架10包括覆盖于金属管腔支架11内表面的内层膜本体13、覆盖于金属管腔支架11外表面的外层膜本体15及设于内层膜本体13与外层膜本体15之间的增强网17。其中,内层膜本体13的表面设有形状及尺寸与该外表面相同的增强区,增强网17位于该增强区内,并覆盖金属管腔支架11的内表面,内层膜本体13和增强网17构成阻流膜12。在覆膜管腔支架10的制作过程中,可先将内层膜本体13和增强网17通过常规工艺例如缝合、粘合或热压合形成一整体即一块阻流膜后再固定到金属管腔支架11的内表面;也可以直接将增强网17覆盖到金属管腔支架11的内表面,将内层膜本体13覆盖到增强网17上,将外层膜本体15覆盖在金属管腔支架11的外表面,然后三者一次热压合成型固定在金属管腔支架11上。内层膜本体13、外层膜本体15及增强网17在金属管腔支架11的镂空处111相互结合为一体。可以理解的是,其他实施例中,金属管腔支架11、内层膜本体13、外层膜本体15及增强网17也可以通过粘合剂粘合为一体,或者通过缝线缝合的方式缝合为一体。 Referring again to FIG. 3, the stented stent 10 includes an inner membrane body 13 covering the inner surface of the metal lumen stent 11, an outer membrane body 15 covering the outer surface of the metal lumen stent 11, and an inner membrane. A reinforcing mesh 17 between the body 13 and the outer film body 15. Wherein, the surface of the inner film body 13 is provided with a reinforcing region having the same shape and size as the outer surface, the reinforcing mesh 17 is located in the reinforcing region, and covers the inner surface of the metal lumen support 11, the inner film body 13 and the reinforcement The mesh 17 constitutes the flow blocking film 12. In the manufacturing process of the laminar tube stent 10, the inner film body 13 and the reinforcing mesh 17 may be first formed into a whole body, that is, a baffle film, and then fixed to the metal tube by a conventional process such as stitching, bonding or thermocompression bonding. The inner surface of the cavity holder 11; the reinforcing mesh 17 may be directly covered to the inner surface of the metal lumen support 11, the inner film body 13 is covered on the reinforcing mesh 17, and the outer film body 15 is covered on the metal lumen support. The outer surface of the elbow 11 is then fixed to the metal lumen support 11 by a hot press synthesis. The inner film body 13, the outer film body 15, and the reinforcing mesh 17 are integrally joined to each other at the hollow portion 111 of the metal lumen support 11. It can be understood that in other embodiments, the metal lumen support 11, the inner film body 13, the outer film body 15 and the reinforcing mesh 17 may also be bonded together by an adhesive or stitched by suture stitching. As one.
内层膜本体13和外层膜本体15用于使覆膜管腔支架10形成侧面密封的管腔,使血流仅从覆膜管腔支架10的管腔中流过,且不会从覆膜管腔支架10的侧面渗出。内层膜本体13和外层膜本体15的厚度皆可介于0.01-0.06毫米,内层膜本体13、外层膜本体15和增强层的厚度之和,即阻流膜的厚度范围为0.06毫米至0.72毫米,以便于覆膜管腔支架10具有较小的外径的同时,内层膜本体13和外层膜本体15也可以有效地防止血液从覆膜管腔支架10的内部流向覆膜管腔支架10的外部。本实施例中,内层膜本体13和外层膜本体15的厚度均为0.01毫米,且内层膜本体13和外层膜本体15均为ePTFE(膨体聚四氟乙烯)。如此,内层膜本体13和外层膜本体15分别包覆于金属管腔支架11的内外表面,从而减小了金属管腔支架11释放出金属离子的可能,也减小了金属管腔支架11的表面氧化层颗粒脱落的可能,保证了覆膜管腔支架10植入体内后的安全性。The inner membrane body 13 and the outer membrane body 15 are used to form the stent lumen 10 to form a side-sealed lumen, so that blood flow only flows through the lumen of the stented stent 10 without covering the membrane The side of the lumen support 10 seeps out. The thickness of the inner film body 13 and the outer film body 15 may be between 0.01 and 0.06 mm, and the sum of the thicknesses of the inner film body 13, the outer film body 15 and the reinforcing layer, that is, the thickness of the flow blocking film is 0.06. From millimeters to 0.72 mm, so that the stented stent 10 has a smaller outer diameter, the inner membrane body 13 and the outer membrane body 15 can also effectively prevent blood from flowing from the inside of the stent lumen stent 10 The exterior of the membrane lumen stent 10. In the present embodiment, the thickness of the inner film body 13 and the outer film body 15 are both 0.01 mm, and the inner film body 13 and the outer film body 15 are both ePTFE (expanded polytetrafluoroethylene). Thus, the inner film body 13 and the outer film body 15 are respectively coated on the inner and outer surfaces of the metal lumen support 11, thereby reducing the possibility of metal ion release from the metal lumen support 11, and reducing the metal lumen support. The possibility of surface oxide layer detachment of 11 ensures the safety of the stented stent 10 after implantation into the body.
可以理解的是,其他实施例中,内层膜本体13和外层膜本体15也可以均分别由多层ePTFE单层膜叠加形成,由此构成两组相对的膜。It can be understood that in other embodiments, the inner film body 13 and the outer film body 15 may also each be formed by superposing a plurality of layers of ePTFE single layer film, thereby forming two sets of opposing films.
增强网17由多根增强件交错排布形成,其目数范围为50目至120目。多根增强件交错排布可以是两组增强件一上一下相交形成“十”字网状结构或不具有网孔的“十”字结构,或者直接在一块较大的增强布上模压形成的多个“十字”结构,或者通过针织形成网格结构。每组增强件内包括多根相互平行的增强件。增强网可为针织网布或编织网布,其厚度范围为0.1毫米至0.6毫米。增强件可以采用高分子材料(例如PTFE,PET或超高分子量聚乙烯等)制成。增强件为截面呈圆形的丝状结构或截面呈扁型的带状结构,且直径或最大截面尺寸范围优选为0.05毫米至0.6毫米。当增强网17的网线即增强件的直径或最大截面尺寸小于0.05毫米时,增强网17的韧性和强度可能较差,抗撕裂及抗划孔能力较差,当覆膜管腔支架10植入体内后,阻流膜12仍可能被血流冲击破损或被缝合线造成划孔;当增强网17的网线的直径或最大截面尺寸大于0.6毫米时,覆膜管腔支架10的径向压缩尺寸明显增大,使得覆膜管腔支架10径向压缩后无法装载进内径较小的输送导管,从而无法通过内径较小的输送导管植入体内,或导致覆膜管腔支架10在输送导管内的推送力增大以致难以使用。本实施例中,增强网17围绕金属管腔支架11形成管状结构;增强网17采用PTFE (聚四氟乙烯)制成,且增强网17的增强件(即网线)的直径为0.3毫米;增强网17的多个网孔的大小及形状均相同。如此,阻流膜12内的交错排布的网线不仅可以提高阻流膜12的韧性和强度,还可以在将阻流膜12通过缝线穿过网孔缝合至金属管腔支架上时阻止缝合针或缝合线在阻流膜12尤其是内层膜本体13上划出较大的孔,从而提高阻流膜12的抗撕裂能力和抗划孔能力。而且,增强网17有多个网孔、多根围绕网孔的网线及多个由两根相交网线的交点形成的凸点(即“十”字结构中两条线的交叉点),当增强网17位于膜体表面时,可以增加阻流膜12的粗糙度,提高覆膜管腔支架10与其植入的管腔壁之间的摩擦力,降低了覆膜管腔支架10在管腔内移位的风险。此外,在金属管腔支架11的镂空处1111,内层膜本体13、外层膜本体15及增强网17粘合在一起,故,镂空处1111内填充的阻流膜12及阻流膜12内的增强网17的网线均成为阻挡金属管腔支架11在阻流膜12内移动的障碍物,从而防止了金属管腔支架11在阻流膜12内移动的风险,提高了阻流膜12和金属管腔支架11之间的结合强度,降低了阻流膜12在植入人体后从金属管腔支架11上脱落的风险。另外,增强网17具有网孔,可允许血流穿过;若内层膜本体13某个地方有血液渗入,则血液可以在网孔内散开,避免了血液集中于血液渗入处,降低了内层膜本体13的血液渗入处的压力,防止内层膜本体13的血液渗入处的裂痕继续扩大,延长了覆膜管腔支架10的使用寿命。The reinforcing mesh 17 is formed by staggering a plurality of reinforcing members having a mesh number ranging from 50 mesh to 120 mesh. The plurality of reinforcing members may be arranged in a staggered arrangement in which the two sets of reinforcing members are vertically intersected to form a "ten" word mesh structure or a "ten" structure having no mesh, or directly formed on a large reinforcing cloth. A plurality of "cross" structures, or a mesh structure by knitting. Each set of reinforcements includes a plurality of mutually parallel reinforcements. The reinforcing mesh may be a knitted mesh or a woven mesh having a thickness ranging from 0.1 mm to 0.6 mm. The reinforcing member can be made of a polymer material such as PTFE, PET or ultra high molecular weight polyethylene. The reinforcing member is a wire-like structure having a circular cross section or a strip-shaped structure having a flat cross section, and the diameter or the maximum sectional size preferably ranges from 0.05 mm to 0.6 mm. When the diameter of the reinforcing wire or the maximum cross-sectional dimension of the reinforcing mesh 17 is less than 0.05 mm, the toughness and strength of the reinforcing mesh 17 may be poor, and the tear resistance and the anti-scratching ability are poor, when the laminar stent is implanted After entering the body, the baffle 12 may still be damaged by blood flow or by the suture; when the diameter or maximum cross-sectional dimension of the mesh of the reinforcing mesh 17 is greater than 0.6 mm, the radial compression of the stent graft 10 The size is significantly increased, so that the stent graft 10 can not be loaded into the delivery catheter with a smaller inner diameter after being radially compressed, so that it cannot be implanted into the body through a delivery catheter having a smaller inner diameter, or the stented stent 10 is in the delivery catheter. The pushing force inside is increased to make it difficult to use. In this embodiment, the reinforcing mesh 17 forms a tubular structure around the metal lumen support 11; the reinforcing mesh 17 is made of PTFE Made of (polytetrafluoroethylene), and the reinforcing member (i.e., the mesh) of the reinforcing net 17 has a diameter of 0.3 mm; the plurality of meshes of the reinforcing net 17 have the same size and shape. Thus, the staggered network wires in the baffle film 12 can not only improve the toughness and strength of the baffle film 12, but also prevent the suture film 12 from being sutured when sutured through the mesh through the mesh to the metal lumen stent. Needles or sutures draw larger holes in the baffle film 12, particularly the inner film body 13, thereby improving the tear resistance and resistance to puncturing of the baffle film 12. Moreover, the reinforcing net 17 has a plurality of meshes, a plurality of mesh lines surrounding the mesh, and a plurality of bumps formed by intersections of the two intersecting mesh lines (ie, intersections of two lines in the "ten" structure), when enhanced When the net 17 is located on the surface of the membrane body, the roughness of the obstruction membrane 12 can be increased, the friction between the stent lumen 10 and the lumen wall of the stent can be increased, and the stent lumen 10 can be reduced in the lumen. The risk of shifting. In addition, in the hollow portion 1111 of the metal lumen support 11, the inner film body 13, the outer film body 15 and the reinforcing mesh 17 are bonded together, so that the choke film 12 and the choke film 12 are filled in the hollow portion 1111. The mesh of the inner reinforcing mesh 17 becomes an obstacle for blocking the movement of the metal lumen support 11 in the choke film 12, thereby preventing the risk of the metal lumen support 11 moving in the choke film 12, and the choke film 12 is improved. The bonding strength with the metal lumen stent 11 reduces the risk of the choke membrane 12 falling off the metal lumen stent 11 after implantation in the human body. In addition, the reinforcing mesh 17 has a mesh hole for allowing blood to pass through; if blood is infiltrated somewhere in the inner film body 13, the blood can be dispersed in the mesh, thereby preventing blood from being concentrated in the blood infiltration, reducing the blood. The pressure at the blood infiltration of the inner membrane body 13 prevents the cracks in the blood infiltration of the inner membrane body 13 from continuing to expand, prolonging the service life of the stent lumen stent 10.
优选地,增强网17的任一网孔上相距最远的两点之间的距离,均小于金属管腔支架11的面积最小的环状结构112上的相距最远的两点之间的距离。即,每个镂空处对应有至少部分增强网,例如至少有一个网格结构。如此,当需要在金属管腔支架11的镂空处111缝合瓣叶时,增强网17可以更好且更有效地提高阻流膜12的抗撕裂和抗划孔性能。Preferably, the distance between the two most distant points on any of the meshes of the reinforcing mesh 17 is less than the distance between the two most distant points on the annular structure 112 having the smallest area of the metal lumen support 11. . That is, each cutout corresponds to at least a portion of the reinforcing mesh, such as at least one mesh structure. As such, when it is desired to suture the leaflets at the hollow 111 of the metal lumen support 11, the reinforcing mesh 17 can better and more effectively improve the tear resistance and puncturing resistance of the flow blocking film 12.
需要说明的是,本实施例中的瓣叶20可通过缝线穿过网孔的缝合方式连接于覆膜管腔支架10上;由于覆膜管腔支架10的阻流膜12内具有网线,当瓣叶20通过连有缝合线的针缝于覆膜管腔支架10上时,由于增强件自身的抗拉强度高于膜本体的抗拉强度,针不易在阻流膜12上划出较大的通孔,且围合形成网孔的增强件会限制缝线的滑动,减小了瓣叶20从覆膜管腔支架10上脱落的风 险,延长了医疗器械100的使用寿命。It should be noted that the leaflet 20 in this embodiment can be connected to the stented stent 10 by suture through the mesh through the mesh; since the choke membrane 12 of the stented stent 10 has a mesh line therein, When the leaflet 20 is sewn to the stented stent 10 through the needle with the suture attached, since the tensile strength of the reinforcing member itself is higher than the tensile strength of the membrane body, the needle is not easily drawn on the blocking membrane 12 The large through hole, and the reinforcement forming the mesh, restricts the sliding of the suture, reducing the wind that the leaflet 20 falls off the laminar lumen support 10. The risk extends the life of the medical device 100.
可以理解的是,其他实施例中,增强网17也可以根据实际需要,逐片的设置于外层膜本体15与内层膜本体13之间的需要提高抗撕裂性能及抗划孔性能的位置。还可以理解的是,其他实施例中,增强网17的增强件也可以呈扁带状。还可以理解的是,其他实施例中,呈丝状的增强件的截面也可以呈三角形、四边形、五边形等其他形状。It can be understood that, in other embodiments, the reinforcing mesh 17 can also be disposed between the outer film body 15 and the inner film body 13 piece by piece according to actual needs, and needs to improve tear resistance and anti-hole drilling performance. position. It will also be appreciated that in other embodiments, the reinforcement of the reinforcing mesh 17 may also be in the form of a flat strip. It can also be understood that in other embodiments, the cross section of the filament-shaped reinforcing member may also have other shapes such as a triangle, a quadrangle, a pentagon or the like.
可以理解的是,当需要缝合其他元件至管腔支架11的外表面时,可将阻流膜12覆盖管腔支架11的外表面,而将本实施例中的外层膜本体15设于管腔支架11的内表面。It can be understood that when it is required to suture other components to the outer surface of the lumen stent 11, the baffle film 12 can be covered on the outer surface of the lumen stent 11, and the outer membrane body 15 in this embodiment is placed on the tube. The inner surface of the cavity holder 11.
可以理解的是,其他实施例中,若医疗器械为编织网状心脏缺损封堵器或带有编织网状封堵结构的左心耳封堵器,阻流膜12的边缘也通过线缝合的方式设于封堵器的内部并与封堵器的网状结构相连;此时,阻流膜12包括膜本体和位于膜本体的增强区内的增强件,所述增强区可位于膜本体的边缘,也可与膜本体的形状与尺寸匹配,即可仅在膜本体的边缘设有增强层,也可在膜本体的整个表面设增强层。由于阻流膜12内具有网线,当阻流膜12通过连有缝合线的针缝于封堵器的内部时,针或缝合线不易在阻流膜12上划出较大的通孔,减小了阻流膜12从封堵器上脱落的风险,延长了封堵器的使用寿命。此外,阻流膜12的内部具有网线,阻流膜12的韧性和强度也较强,在血流的冲击下也不容易撕裂,提高了封堵器的封堵效果及使用寿命。It can be understood that, in other embodiments, if the medical device is a woven mesh-shaped heart defect occluder or a left atrial appendage occluder with a woven mesh plug structure, the edge of the choke film 12 is also stitched by a wire. Provided inside the occluder and connected to the mesh structure of the occluder; at this time, the flow blocking film 12 includes a film body and a reinforcement located in the reinforcing region of the film body, and the reinforcing region may be located at the edge of the film body It is also possible to match the shape and size of the film body, that is, the reinforcing layer may be provided only at the edge of the film body, or the reinforcing layer may be provided on the entire surface of the film body. Since the choke film 12 has a mesh line, when the choke film 12 is sewn into the inside of the occluder by a needle connected with a suture, the needle or the suture is difficult to draw a large through hole on the choke film 12, The risk of the choke film 12 falling off the occluder is reduced, and the life of the occluder is prolonged. In addition, the inside of the choke film 12 has a mesh line, and the toughness and strength of the choke film 12 are also strong, and it is not easily torn under the impact of blood flow, thereby improving the plugging effect and service life of the occluder.
可以理解的是,在本发明的其他实施例中,增强件还可以其他形式设于膜本体表面,例如,增强件可以只有一根,其呈环状地设于膜本体的边缘区或呈螺纹式设于膜本体的表面,或者通过此根增强件编织形成具有多个网孔的网布。It can be understood that, in other embodiments of the present invention, the reinforcing member may be disposed on the surface of the film body in other forms. For example, the reinforcing member may have only one piece, which is annularly disposed on the edge portion of the film body or is threaded. The pattern is disposed on the surface of the film body, or is woven by the root reinforcement to form a mesh having a plurality of meshes.
请参阅图5,本发明第二实施例的阻流膜12a包括外层膜本体15a及设于外层膜本体15a内的增强网17a。本实施中,外层膜本体15a包括内侧子层151a及外侧子层153a,其在内侧子层151a和外侧子层153a相对的两个表面设有形状及尺寸与该两个表面匹配的增强区;增强网17a设于内侧子层151a及外侧子层153a之间,并位于该增强区内。优选地,本实施例中,增强网17a通过热压的方式预先设于内侧子层151a及外侧子层153a之间。如此,增强网17a与外层 膜本体15a之间具有较强的结合力,增强网17a难以从外层膜本体15a上脱离。此外,若植入医疗器械还具有如第一实施例所述的内层膜本体,且该植入医疗器械包括金属管腔支架时,具有增强网17a的外层膜本体15a可再通过热压的方法与内层膜本体分别设于管腔支架的外表面和内表面,并在镂空处结合在一起,如此,增强网17a先后经过两次热压工艺与内层膜本体及外层膜本体粘结,更难以从内层膜本体及外层膜本体中脱离。Referring to Fig. 5, a flow blocking film 12a according to a second embodiment of the present invention includes an outer film body 15a and a reinforcing mesh 17a provided in the outer film body 15a. In this embodiment, the outer film body 15a includes an inner sub-layer 151a and an outer sub-layer 153a, and the two opposite surfaces of the inner sub-layer 151a and the outer sub-layer 153a are provided with reinforcing regions having shapes and sizes matching the two surfaces. The reinforcing mesh 17a is disposed between the inner sub-layer 151a and the outer sub-layer 153a and located in the enhanced region. Preferably, in the present embodiment, the reinforcing mesh 17a is preliminarily disposed between the inner sub-layer 151a and the outer sub-layer 153a by means of hot pressing. Thus, the reinforcing mesh 17a and the outer layer There is a strong bonding force between the film bodies 15a, and it is difficult for the reinforcing mesh 17a to be detached from the outer film body 15a. Furthermore, if the implanted medical device further has the inner layer membrane body as described in the first embodiment, and the implanted medical device comprises a metal lumen stent, the outer membrane body 15a having the reinforcing mesh 17a can be further subjected to hot pressing The method and the inner membrane body are respectively disposed on the outer surface and the inner surface of the lumen support, and are combined at the hollowed out portion. Thus, the reinforcing mesh 17a is subjected to two hot pressing processes and the inner film body and the outer film body. Bonding makes it more difficult to detach from the inner film body and the outer film body.
可以理解的是,其他实施例中,若医疗器械为封堵器,则可直接将阻流膜12a置于封堵器的内部,且将位于其边缘区的增强层直接与封堵本体相连。It can be understood that, in other embodiments, if the medical device is an occluder, the baffle film 12a can be directly placed inside the occluder, and the reinforcing layer located at the edge region thereof is directly connected to the occluding body.
请参阅图6,本发明第三实施例提供的覆膜管腔支架10b与覆膜管腔支架10大体上相同,包括金属管腔支架11b及设于金属管腔支架11b上的阻流膜12b。覆膜管腔支架10b与覆膜管腔支架10的不同之处在于,覆膜12b包括设于金属管腔支架11b的内表面的内层膜本体13b、设于金属管腔支架11b的外表面的外层膜本体15b及位于内层膜本体13b与外层膜本体15b之间的多根增强件17b。外层膜本体15b的表面皆覆盖有增强件17b,增强件17b和外层膜本体15b构成阻流膜。增强件17b可采用PTFE(聚四氟乙烯)、PET(聚对苯二甲酸乙二酯)、PE(聚乙烯)、尼龙、玻璃纤维、碳纤维、超高分子量聚乙烯或不锈钢等材料制成,其直径范围为0.05毫米至0.6毫米。Referring to FIG. 6, the stented stent 10b of the third embodiment of the present invention is substantially the same as the stented stent 10, and includes a metal lumen stent 11b and a baffle film 12b disposed on the metal lumen stent 11b. . The covered lumen stent 10b is different from the stented stent 10 in that the membrane 12b includes an inner membrane body 13b disposed on the inner surface of the metal lumen stent 11b, and is disposed on the outer surface of the metal lumen stent 11b. The outer film body 15b and the plurality of reinforcing members 17b between the inner film body 13b and the outer film body 15b. The surface of the outer film body 15b is covered with a reinforcing member 17b, and the reinforcing member 17b and the outer layer film body 15b constitute a flow blocking film. The reinforcing member 17b may be made of PTFE (polytetrafluoroethylene), PET (polyethylene terephthalate), PE (polyethylene), nylon, glass fiber, carbon fiber, ultra high molecular weight polyethylene or stainless steel. Its diameter ranges from 0.05 mm to 0.6 mm.
优选地,本实施例中,增强件17b为截面为圆形的丝状结构;每根增强件17b均形成一个围绕金属管腔支架11b的环形结构,且多根增强件17b相互平行;相邻两根增强件17b之间的沿金属管腔支架11b的轴向的间距小于金属管腔支架11b的面积最小的环形结构上的相距最远的两点之间的距离。如此,当需要在金属管腔支架11b的镂空处111b缝合瓣叶时,增强件17b可以提高内层膜本体13b与外层膜本体15b组成的膜本体的整体的抗撕裂和抗划孔性能。Preferably, in the embodiment, the reinforcing member 17b is a wire-like structure having a circular cross section; each reinforcing member 17b forms an annular structure surrounding the metal lumen bracket 11b, and the plurality of reinforcing members 17b are parallel to each other; adjacent The distance between the two reinforcing members 17b in the axial direction of the metal lumen bracket 11b is smaller than the distance between the two most distant points on the annular structure having the smallest area of the metal lumen bracket 11b. Thus, when it is required to suture the leaflets at the hollow portion 111b of the metal lumen support 11b, the reinforcing member 17b can improve the overall tear resistance and puncturing resistance of the film body composed of the inner film body 13b and the outer film body 15b. .
多根增强件17b不仅可以提高外层膜本体15b的韧性和强度,还可以阻挡缝合针在阻流膜上划出较大的孔,增强件不仅可以提高阻流膜的抗撕裂能力,还可以提高阻流膜的抗划孔能力。而且,多根增强件17b相互平行,且相邻两根增强件17b之间具有空隙,如此,还可以增加阻流膜的粗糙度,提高覆膜管腔支架10b与其植入的管腔壁之间的摩擦力,降低了覆膜管腔支架10b在管腔 内移位的风险。此外,在金属管腔支架11b的镂空处111b,内层膜本体13b、外层膜本体15b及增强件17b粘合在一起,故,镂空处111b内填充的阻流膜及阻流膜内的增强件17b的网线均成为阻挡金属管腔支架11b在阻流膜内移动的障碍物,从而防止了金属管腔支架11b在阻流膜内移动的风险,提高了阻流膜和金属管腔支架11b之间的结合强度,降低了阻流膜在植入人体后从金属管腔支架11b上脱落的风险。另外,相邻两根增强件17b之间具有间隙,可允许血流穿过;若内层膜本体13b某个地方有血液渗入,则血液可以在空隙内散开,避免了血液集中于血液渗入处,降低了内层膜本体13b的血液渗入处的压力,防止内层膜本体13b的血液渗入处的裂痕继续扩大,延长了覆膜管腔支架10b的使用寿命。The plurality of reinforcing members 17b can not only improve the toughness and strength of the outer layer membrane body 15b, but also block the suture needle from drawing a large hole in the choke membrane, and the reinforcing member can not only improve the tear resistance of the choke membrane, but also The anti-cratering ability of the choke film can be improved. Moreover, the plurality of reinforcing members 17b are parallel to each other and have a gap between the adjacent two reinforcing members 17b, so that the roughness of the choke film can be increased, and the laminar lumen stent 10b and the lumen wall of the implantation can be improved. Friction between the lowering of the stent lumen 10b in the lumen The risk of internal shifting. In addition, in the hollow portion 111b of the metal lumen support 11b, the inner film body 13b, the outer layer film body 15b and the reinforcing member 17b are bonded together, so that the choke film and the choke film filled in the hollow portion 111b are The mesh of the reinforcing member 17b acts as an obstacle to block the movement of the metal lumen support 11b in the choke membrane, thereby preventing the risk of the metal lumen support 11b moving within the choke membrane, and improving the choke membrane and the metal lumen stent. The bonding strength between 11b reduces the risk of the choke film falling off the metal lumen stent 11b after implantation in the human body. In addition, there is a gap between the adjacent two reinforcing members 17b to allow blood to pass through; if blood is infiltrated somewhere in the inner film body 13b, the blood can be dispersed in the gap, thereby preventing blood from being concentrated in the blood. At this point, the pressure at the blood infiltration site of the inner membrane body 13b is lowered, and the crack at the blood infiltration site of the inner membrane body 13b is prevented from continuing to expand, prolonging the service life of the stent lumen stent 10b.
可以理解的是,其他实施例中,多根增强件17b中的部分增强件相互平行,其余增强件相互交错排列形成具有网孔的网状结构或不具有网孔的“十”字增强垫结构。还可以理解的是,其他实施例中,多根增强件17b中的部分增强件呈环状结构,其余增强件的长度方向平行于金属管腔支架11b的轴向。It can be understood that, in other embodiments, some of the plurality of reinforcing members 17b are parallel to each other, and the remaining reinforcing members are alternately arranged to form a mesh structure having a mesh or a "ten" reinforcing pad structure having no mesh. . It will also be understood that in other embodiments, a portion of the plurality of reinforcing members 17b has an annular structure, and the remaining reinforcing members have a longitudinal direction parallel to the axial direction of the metal lumen support 11b.
请参阅图7,本发明第四实施例提供的覆膜管腔支架10c与覆膜管腔支架10b大体上相同,不同之处在于,覆膜管腔支架10c的多根增强件17c交错排布,形成具有多个尺寸及形状不同的网孔的增强网,且任一网孔上相距最远的两点之间的距离均小于金属管腔支架11c的面积最小的镂空112c上的相距最远的两点之间的距离。如此,当需要在金属管腔支架11c的镂空111c缝合时,交错排布的增强件17c可以提高膜层多方向的抗撕裂和抗划孔性能。Referring to FIG. 7, the stented stent holder 10c according to the fourth embodiment of the present invention is substantially the same as the stented stent stent 10b, except that the plurality of reinforcing members 17c of the stented stent stent 10c are staggered. Forming a reinforcing mesh having a plurality of meshes having different sizes and shapes, and the distance between the two points farthest from each of the meshes is smaller than the distance between the hollows 112c having the smallest area of the metal lumen support 11c The distance between the two points. Thus, when it is required to suture the hollow 111c of the metal lumen support 11c, the staggered reinforcing members 17c can improve the tear resistance and the puncturing resistance of the film in multiple directions.
正是由于具有该增强网的阻流膜内的交错排布的网线不仅可以提高阻流膜的韧性和强度,还可以可阻挡缝合针和缝合线在阻流膜上划出较大的孔,增强件不仅可以提高阻流膜的抗撕裂能力,还可以提高阻流膜的抗划孔能力。增强网有多个网孔、多根围绕网孔的网线及多个由两根相交网线的交点形成的凸点,如此,还可以增加具有该增强网的阻流膜的粗糙度,提高具有该阻流膜的覆膜管腔支架与其植入的管腔壁之间的摩擦力,降低了具有该阻流膜的覆膜管腔支架在管腔内移位的风险。此外,在覆膜管腔支架的金属管腔支架的镂空处,内层膜本体、外层膜本体及增强网粘合在一起,故,镂空处内填充的阻流膜及阻 流膜内的增强网的网线均成为阻挡金属管腔支架在阻流膜内移动的障碍物,从而防止了金属管腔支架在阻流膜内移动的风险,提高了阻流膜和金属管腔支架之间的结合强度,降低了阻流膜在植入人体后从金属管腔支架上脱落的风险。另外,该增强网具有网孔,可允许血流穿过;若内层膜本体某个地方有血液渗入,则血液可以在网孔内散开,避免了血液集中于血液渗入处,降低了内层膜本体的血液渗入处的压力,防止内层膜本体的血液渗入处的裂痕继续扩大,延长了具有该阻流膜的覆膜管腔支架的使用寿命。It is precisely because of the staggered arrangement of the mesh line in the barrier film of the reinforcing mesh not only can improve the toughness and strength of the choke film, but also can block the suture needle and the suture to draw a larger hole in the choke film. The reinforcing member not only improves the tear resistance of the choke film, but also improves the anti-cratering ability of the choke film. The reinforcing net has a plurality of meshes, a plurality of mesh wires surrounding the mesh holes, and a plurality of bumps formed by intersections of the two intersecting mesh wires, so that the roughness of the choke film having the reinforcing mesh can be increased, and the The friction between the stented stent of the baffle and the wall of the lumen of the implant reduces the risk of displacement of the stented stent with the baffle in the lumen. In addition, in the hollow of the metal lumen stent of the stented stent, the inner membrane body, the outer membrane body and the reinforcing mesh are bonded together, so that the choke membrane and the resistance filled in the hollow portion are blocked. The mesh of the reinforcing mesh in the flow film becomes an obstacle to block the movement of the metal lumen bracket in the choke membrane, thereby preventing the risk of the metal lumen stent moving in the choke membrane, and improving the choke membrane and the metal lumen. The strength of the bond between the stents reduces the risk of the choke membrane falling off the metal lumen stent after implantation in the human body. In addition, the reinforcing mesh has a mesh to allow blood to pass through; if blood is infiltrated in a certain part of the inner film body, the blood can be dispersed in the mesh, thereby preventing blood from being concentrated in the blood infiltration and reducing the inside. The pressure at the place where the blood is infiltrated into the film body prevents the crack of the blood infiltration portion of the inner film body from continuing to expand, prolonging the service life of the film tube stent having the flow blocking film.
以上所述实施例的各技术特征可以进行任意的组合,为使描述简洁,未对上述实施例中的各个技术特征所有可能的组合都进行描述,然而,只要这些技术特征的组合不存在矛盾,都应当认为是本说明书记载的范围。The technical features of the above-described embodiments may be arbitrarily combined. For the sake of brevity of description, all possible combinations of the technical features in the above embodiments are not described. However, as long as there is no contradiction between the combinations of these technical features, All should be considered as the scope of this manual.
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。 The above-described embodiments are merely illustrative of several embodiments of the present invention, and the description thereof is more specific and detailed, but is not to be construed as limiting the scope of the invention. It should be noted that a number of variations and modifications may be made by those skilled in the art without departing from the spirit and scope of the invention. Therefore, the scope of the invention should be determined by the appended claims.

Claims (14)

  1. 一种阻流膜,包括膜本体,其特征在于,所述阻流膜还包括设于所述膜本体表面或膜本体内部的增强层,所述增强层的抗拉强度大于所述膜本体的抗拉强度。A flow blocking film, comprising: a film body, wherein the flow blocking film further comprises a reinforcing layer disposed on a surface of the film body or inside the film body, wherein the reinforcing layer has a tensile strength greater than that of the film body tensile strength.
  2. 根据权利要求1所述的阻流膜,其特征在于,所述膜本体包括两组相对的膜,所述增强层夹设于所述两组膜之间。The baffle film according to claim 1, wherein the film body comprises two sets of opposing films, and the reinforcing layer is interposed between the two sets of films.
  3. 根据权利要求1所述的阻流膜,其特征在于,所述增强层包括多根增强件,所述多根增强件交错排布形成增强网;或所有所述增强件相互平行;或所述多根增强件中一部分增强件交错排布形成增强网,另一部分增强件相互平行。The baffle film according to claim 1, wherein the reinforcing layer comprises a plurality of reinforcing members staggered to form a reinforcing mesh; or all of the reinforcing members are parallel to each other; or A portion of the reinforcements of the plurality of reinforcements are staggered to form a reinforcing mesh, and the other portions of the reinforcement are parallel to each other.
  4. 根据权利要求3所述的阻流膜,其特征在于,所述增强件的抗拉强度大于所述膜本体的抗拉强度。The flow-blocking film according to claim 3, wherein the reinforcing member has a tensile strength greater than a tensile strength of the film body.
  5. 根据权利要求1所述的阻流膜,其特征在于,所述增强层位于所述膜本体的边缘。The flow blocking film of claim 1 wherein said reinforcing layer is located at an edge of said film body.
  6. 根据权利要求1所述的阻流膜,其特征在于,所述增强层与所述膜本体重合。The baffle film according to claim 1, wherein the reinforcing layer is in weight with the film.
  7. 根据权利要求3所述的阻流膜,其特征在于,所述增强网的目数范围为50目至120目。The flow-blocking film according to claim 3, wherein the reinforcing mesh has a mesh number ranging from 50 mesh to 120 mesh.
  8. 根据权利要求3所述的阻流膜,其特征在于,所述增强件的直径范围为0.05毫米至0.6毫米。The baffle film according to claim 3, wherein the reinforcing member has a diameter ranging from 0.05 mm to 0.6 mm.
  9. 根据权利要求1所述的阻流膜,其特征在于,所述阻流膜的厚度范围为0.06毫米至0.72毫米。The baffle film according to claim 1, wherein the flow blocking film has a thickness ranging from 0.06 mm to 0.72 mm.
  10. 一种植入医疗器械,包括器械本体和如权利要求1-9任一项所述的阻流膜,其特征在于,所述阻流膜的含有所述增强层的部分与所述器械本体相连。An implantable medical device comprising a device body and a flow blocking film according to any of claims 1-9, wherein the portion of the baffle film containing the reinforcing layer is coupled to the instrument body.
  11. 根据权利要求10所述的植入医疗器械,其特征在于,所述器械本体包括具有多个波形环状结构的管腔支架,至少部分相邻的波形环状结构之间具有镂空,所述阻流膜位于所述管腔支架的至少一个表面,并至少覆盖部分镂空。The implantable medical device according to claim 10, wherein said instrument body comprises a lumen support having a plurality of corrugated annular structures, at least partially adjacent of said corrugated annular structures having a hollow, said resistance The flow film is located on at least one surface of the lumen support and covers at least a portion of the hollow.
  12. 根据权利要求11所述的植入医疗器械,其特征在于,至少一个镂空与部分增强层对应。The implantable medical device of claim 11 wherein at least one of the hollows corresponds to a portion of the reinforcement layer.
  13. 根据权利要求11所述的植入医疗器械,其特征在于,所述管腔支架还 包括覆膜,所述覆膜和所述阻流膜设于所述管腔支架的相对两表面,所述覆膜在镂空处与所述阻流膜相连。The implantable medical device according to claim 11, wherein said lumen stent is further The film is covered, and the film and the flow blocking film are disposed on opposite surfaces of the lumen holder, and the film is connected to the flow blocking film at a hollow.
  14. 根据权利要求12所述的植入医疗器械,其特征在于,所述器械本体还包括瓣叶,所述瓣叶设于所述管腔支架的腔内,并在镂空处与所述阻流膜内的增强层相连。 The implantable medical device according to claim 12, wherein the instrument body further comprises a leaflet disposed in the lumen of the lumen stent and in the hollow with the obstruction membrane The inner reinforcement layers are connected.
PCT/CN2017/083719 2016-11-15 2017-05-10 Flow blocking membrane and implanted medical device WO2018090576A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611004475.3 2016-11-15
CN201611004475.3A CN108066047B (en) 2016-11-15 2016-11-15 Flow-blocking membrane and implanted medical instrument

Publications (1)

Publication Number Publication Date
WO2018090576A1 true WO2018090576A1 (en) 2018-05-24

Family

ID=62145141

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/083719 WO2018090576A1 (en) 2016-11-15 2017-05-10 Flow blocking membrane and implanted medical device

Country Status (2)

Country Link
CN (1) CN108066047B (en)
WO (1) WO2018090576A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
CN111887171A (en) * 2020-08-27 2020-11-06 温州大学激光与光电智能制造研究院 Multi-functional poultry water feeding device
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
US11166814B2 (en) 2019-08-20 2021-11-09 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
US11202706B2 (en) 2019-05-04 2021-12-21 Vdyne, Inc. Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11273033B2 (en) 2018-09-20 2022-03-15 Vdyne, Inc. Side-delivered transcatheter heart valve replacement
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US11298227B2 (en) 2019-03-05 2022-04-12 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
US11331186B2 (en) 2019-08-26 2022-05-17 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11786366B2 (en) 2018-04-04 2023-10-17 Vdyne, Inc. Devices and methods for anchoring transcatheter heart valve

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110946626B (en) * 2019-12-04 2022-08-09 山东大学齐鲁医院 Expansion type tectorial membrane bracket for obtaining specimen through natural cavity channel, use method and application
CN113413255B (en) * 2021-08-24 2021-11-16 南通欣昌减震器有限公司 Blood vessel supporting rubber stent

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1421183A (en) * 2002-12-20 2003-06-04 周星 Combined vessel strut
CN101953721A (en) * 2010-10-28 2011-01-26 东华大学 Multilayer composite artificial vascular membrane with shape memory function and preparation method thereof
US20130306232A1 (en) * 2011-10-10 2013-11-21 W. L. Gore & Associates, Inc. Devices and methods for attaching support frames to substrates
CN203790082U (en) * 2013-12-31 2014-08-27 江苏省华星医疗器械实业有限公司 Film-coated intravascular stent
CN104114201A (en) * 2012-01-16 2014-10-22 美国医疗设备有限公司 Rotational spun material covered medical appliances and methods of manufacture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607478A (en) * 1996-03-14 1997-03-04 Meadox Medicals Inc. Yarn wrapped PTFE tubular prosthesis
US9295757B2 (en) * 2008-06-10 2016-03-29 Cook Biotech Incorporated Quilted implantable graft
WO2010096824A1 (en) * 2009-02-23 2010-08-26 Bartee Barry K Reinforced ptfe medical barrier
US8821585B2 (en) * 2010-06-14 2014-09-02 Ethicon, Inc. Composite anisotropic tissue reinforcing implants having alignment markers and methods of manufacturing same
CN105105894A (en) * 2015-07-20 2015-12-02 宁波琳盛高分子材料有限公司 Reinforced compound sheathing canal, preparation method and application thereof
CN105943210A (en) * 2015-12-23 2016-09-21 微创心脉医疗科技(上海)有限公司 Intervention apparatus sheath tube and manufacturing method thereof
CN205625989U (en) * 2016-04-11 2016-10-12 东莞科威医疗器械有限公司 Occluder

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1421183A (en) * 2002-12-20 2003-06-04 周星 Combined vessel strut
CN101953721A (en) * 2010-10-28 2011-01-26 东华大学 Multilayer composite artificial vascular membrane with shape memory function and preparation method thereof
US20130306232A1 (en) * 2011-10-10 2013-11-21 W. L. Gore & Associates, Inc. Devices and methods for attaching support frames to substrates
CN104114201A (en) * 2012-01-16 2014-10-22 美国医疗设备有限公司 Rotational spun material covered medical appliances and methods of manufacture
CN203790082U (en) * 2013-12-31 2014-08-27 江苏省华星医疗器械实业有限公司 Film-coated intravascular stent

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11786366B2 (en) 2018-04-04 2023-10-17 Vdyne, Inc. Devices and methods for anchoring transcatheter heart valve
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11273033B2 (en) 2018-09-20 2022-03-15 Vdyne, Inc. Side-delivered transcatheter heart valve replacement
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11298227B2 (en) 2019-03-05 2022-04-12 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
US11202706B2 (en) 2019-05-04 2021-12-21 Vdyne, Inc. Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus
US11179239B2 (en) 2019-08-20 2021-11-23 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
US11166814B2 (en) 2019-08-20 2021-11-09 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
US11331186B2 (en) 2019-08-26 2022-05-17 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
CN111887171A (en) * 2020-08-27 2020-11-06 温州大学激光与光电智能制造研究院 Multi-functional poultry water feeding device

Also Published As

Publication number Publication date
CN108066047B (en) 2020-06-30
CN108066047A (en) 2018-05-25

Similar Documents

Publication Publication Date Title
WO2018090576A1 (en) Flow blocking membrane and implanted medical device
US11135410B2 (en) Devices and methods for treating heart failure
US11571295B2 (en) Mitral valve with free edge support
US9808341B2 (en) Valve apparatus, system and method
JP6392778B2 (en) Geometric control of bending characteristics in artificial heart valve leaflets
JP4565000B2 (en) Multi-layer braided structure to occlude vascular lesions
EP3171786B1 (en) Devices for treating heart failure
CN105491964B (en) Space filling device
AU2004287395B2 (en) Implantable valvular prothesis
EP1682048B1 (en) Implantable valvular prosthesis
JP6240604B2 (en) Expandable occlusion device and method
EP1626681B1 (en) Implantable medical device with constrained expansion
JP2018202235A (en) Improved prosthetic heart valve with leaflet shelving
CN110536657A (en) For redistributing the current divider of atrium blood volume
KR20150097755A (en) Prosthetic valves, frames and leaflets and methods thereof
JP2009512521A (en) Radiopaque bioabsorbable occluder
PL211860B1 (en) Valve stent system
WO2018145535A1 (en) Occlusion device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17872578

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17872578

Country of ref document: EP

Kind code of ref document: A1